Hemophagocytic syndrome: a rare but specific complication of lung transplantation.
Oto
Takahiro
T
Department of Thoracic Surgery, Okayama University Hospital, Okayama, Japan. oto@md.okayama-u.ac.jp
Snell
Gregory I
GI
Goto
Keiji
K
Miyoshi
Shinichiro
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001856:Bone Marrow Examination; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D019520:Living Donors; D016040:Lung Transplantation / Q000009:adverse effects*; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000472:pathogenicity*; D011668:Pulmonary Veno-Occlusive Disease / Q000601:surgery*; D018805:Sepsis / Q000382:microbiology; D017211:Treatment Failure; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents